This is not the most recent version of the article. View current version (21 OCT 2015)

Intervention Review

You have free access to this content

Cognitive behavioural therapy (brief versus standard duration) for schizophrenia

  1. Farooq Naeem1,*,
  2. Saeed Farooq2,
  3. David Kingdon3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 11 APR 2014

Assessed as up-to-date: 7 DEC 2013

DOI: 10.1002/14651858.CD010646.pub2


How to Cite

Naeem F, Farooq S, Kingdon D. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD010646. DOI: 10.1002/14651858.CD010646.pub2.

Author Information

  1. 1

    Queen's University, Department of Psychiatry, Kingston, Ontario, Canada

  2. 2

    Staffordshire University & Black Country Social Partnership NHS Foundation Trust, Centre for Ageing and Mental Health, Wolverhampton, UK

  3. 3

    University of Southampton, Mental Health Group, Southampton, UK

*Farooq Naeem, Department of Psychiatry, Queen's University, Kingston, Ontario, Canada. farooqnaeem@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 11 APR 2014

SEARCH

This is not the most recent version of the article. View current version (21 OCT 2015)

References

References to studies excluded from this review

  1. References to studies excluded from this review
  2. Additional references
Kemp 1998 {published data only}
Levine 1998 {published data only}
  • Levine J, Barak Y, Granek I. Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy 1998;12:3-12.
Lewis 2002 {published data only}
  • Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. British Journal of Psychiatry 2002;43:91-7.
O’Donnell 2003 {published data only}
Turkington 2000 {published data only}
Turkington 2002 {published data only}
  • Turkington D, Kingdon D, Turner T, Insight into Schizophrenia Research Group. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry 2002;180:523-7.
Wykes 2005 {published data only}
  • Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research 2005;77:201-10.

Additional references

  1. References to studies excluded from this review
  2. Additional references
Altman 1996
APA 1994
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edition. Washington, DC: APA, 1994.
Bland 1997
Boissel 1999
  • Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des Indices d'efficacite]. Therapie 1999;54(4):405-11. [PUBMED: 10667106]
Bond 2002
  • Bond F, Dryden W (editors). Handbook of Brief Cognitive Behaviour Therapy. Chichester: John Wiley & Sons, 2002.
Buckley 2007
Churchill 2001
  • Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment 2001; Vol. 5, issue 35.
Cully 2008
  • Cully JA, Teten AL. A Therapist’s Guide to Brief Cognitive Behavioral Therapy. Houston: Department of Veterans Affairs South Central MIRECC, 2008.
Deeks 2000
  • Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28. Cape Town: The Cochrane Collaboration, 2000.
Divine 1992
Donner 2002
Egger 1997
Elbourne 2002
  • Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
Furukawa 2006
  • Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7-10.
Guaiana 2012
  • Guaiana G, Morelli AC, Chiodo D. Cognitive behaviour therapy (group) for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009608]
Gulliford 1999
  • Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876-83.
Hazlett-Stevens 2002
  • Hazlett-Stevens H, Craske MG. Brief cognitive-behavioral therapy: definition and scientific foundations. In: Bond F, Dryden W (editors) editor(s). Handbook of Brief Cognitive Behaviour Therapy. Chichester: John Wiley & Sons, 2002:1-20.
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hutton 2009
Jones 2009a
  • Jones C, Campbell C, Cormac I, Hacker D, Meaden A. Cognitive behaviour therapy versus standard care for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007964]
Jones 2009b
  • Jones C, Cormac I, Campbell C, Meaden A, Hacker D. Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007965]
Jones 2012
Kay 1986
  • Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.
Kingdon 2006
Leucht 2005a
  • Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
Leucht 2005b
Leucht 2007
  • Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
Marshall 2000
  • Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
McGrath 2008
McIntosh 2006
Mueser 2004
NICE 2009
  • NICE. Schizophrenia (update) March 2009. http://www.nice.org.uk/CG82 (accessed 13 Dec 2011).
Overall 1962
Saha 2007
  • Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007;64(10):1123-31.
Schünemann 2008
  • Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
Ukoumunne 1999
  • Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PG. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92.
Wykes 2008
  • Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 2008;34(3):523-37.
Xia 2009
  • Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.